MedTrace Logo

Wound Dressings for Hidradenitis Suppurativa

NCT04194541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-03-14

Study results available
· View outcomes & findings →

Summary

The primary purpose of this research is to determine how the types of wound dressings affect quality of life for people with Hidradenitis Suppurativa (HS).

Conditions

Interventions

DEVICE

Cutimed Sorbact Hydroactive B wound dressing

Wound dressing applied and changed as needed.

DEVICE

Cutimed Siltect wound dressing

Wound dressing applied and changed as needed.

DEVICE

Sorbion Sana multi-star wound dressing

Wound dressing applied and changed as needed.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Hadar Lev-Tov, MD · University of Miami

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2021-03-08
Completion
2021-03-08
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04194541 on ClinicalTrials.gov